CL2011002465A1 - Uso de una fuente de proteina bovina que comprende caseina para mejorar el crecimiento a una edad temprana y/o reducir el riesgo de desarrollo de resistencia a la insulina o diabetes tipo 2 mas adelante en la vida del bebe o nino pequeno - Google Patents
Uso de una fuente de proteina bovina que comprende caseina para mejorar el crecimiento a una edad temprana y/o reducir el riesgo de desarrollo de resistencia a la insulina o diabetes tipo 2 mas adelante en la vida del bebe o nino pequenoInfo
- Publication number
- CL2011002465A1 CL2011002465A1 CL2011002465A CL2011002465A CL2011002465A1 CL 2011002465 A1 CL2011002465 A1 CL 2011002465A1 CL 2011002465 A CL2011002465 A CL 2011002465A CL 2011002465 A CL2011002465 A CL 2011002465A CL 2011002465 A1 CL2011002465 A1 CL 2011002465A1
- Authority
- CL
- Chile
- Prior art keywords
- toddler
- casein
- baby
- risk
- life
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09157244 | 2009-04-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2011002465A1 true CL2011002465A1 (es) | 2012-03-23 |
Family
ID=40802132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2011002465A CL2011002465A1 (es) | 2009-04-03 | 2011-10-03 | Uso de una fuente de proteina bovina que comprende caseina para mejorar el crecimiento a una edad temprana y/o reducir el riesgo de desarrollo de resistencia a la insulina o diabetes tipo 2 mas adelante en la vida del bebe o nino pequeno |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8846612B2 (es) |
| EP (1) | EP2413952B2 (es) |
| CN (1) | CN102378632A (es) |
| AU (1) | AU2010230283B2 (es) |
| BR (1) | BRPI1014065A2 (es) |
| CA (1) | CA2755860A1 (es) |
| CL (1) | CL2011002465A1 (es) |
| ES (1) | ES2570461T5 (es) |
| MX (1) | MX2011010454A (es) |
| MY (1) | MY183275A (es) |
| PL (1) | PL2413952T3 (es) |
| RU (1) | RU2011144581A (es) |
| SG (1) | SG174355A1 (es) |
| TW (1) | TW201039754A (es) |
| WO (1) | WO2010112430A1 (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2514435A1 (en) * | 2011-04-19 | 2012-10-24 | Nestec S.A. | Infant formula for use in the prevention of cardiovascular diseases |
| EP2734049B1 (en) | 2011-06-20 | 2018-05-02 | H.J. Heinz Company Brands LLC | Probiotic compositions and methods |
| AU2012373361B2 (en) | 2012-03-12 | 2016-10-27 | N.V. Nutricia | Process for the humanization of animal skim milk and products obtained thereby |
| SE1251123A1 (sv) * | 2012-10-05 | 2014-04-06 | Indevex Ab Publ | Födoämnesprodukt |
| NZ714202A (en) | 2013-05-10 | 2021-07-30 | Heinz Co Brands H J Llc | Probiotics and methods of use |
| WO2015041515A1 (en) * | 2013-09-19 | 2015-03-26 | N.V. Nutricia | Improved process for the humanization of animal skim milk |
| CN106231924A (zh) * | 2013-11-29 | 2016-12-14 | 雀巢产品技术援助有限公司 | 按年龄定制的具有不同蛋白质含量的营养组合物 |
| EP3082472A1 (en) * | 2013-11-29 | 2016-10-26 | Nestec S.A. | Infant nutrition for improvement in insulin sensitivity later in life |
| EP3145333B1 (en) * | 2014-05-19 | 2020-11-04 | N.V. Nutricia | Infant formula with optimised amino acid profiles |
| PL3145334T3 (pl) * | 2014-05-19 | 2020-06-01 | N.V. Nutricia | Formulacje dojelitowe dla przedwcześnie urodzonych niemowląt zawierające zoptymalizowane poziomy przyjmowania fenyloalaniny |
| WO2016078952A1 (en) * | 2014-11-19 | 2016-05-26 | Nestec S.A. | Use of whey protein micelles and polysaccharides for improving insulin profile |
| AU2016267052B2 (en) | 2015-05-22 | 2022-01-20 | The Bot Of The Leland Stanford Junior University | Treatment of post-bariatric hypoglycemia with GLP-1 antagonists |
| WO2016196804A1 (en) * | 2015-06-04 | 2016-12-08 | Balchem Corporation | Hydration control for choline salts |
| US10653753B2 (en) | 2016-03-04 | 2020-05-19 | Eiger Biopharmaceuticals, Inc. | Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives |
| EP4591853A1 (en) | 2016-11-21 | 2025-07-30 | Amylyx Pharmaceuticals, Inc. | Buffered formulations of exendin (9-39) |
| MX2019009299A (es) | 2017-02-20 | 2019-09-13 | Nestle Sa | Composiciones nutricionales con proteinas parcialmente hidrolizadas para el uso en la induccion de respuesta(s) a la glucosa y/o insulina similar(es) a las observadas con leche humana. |
| US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
| EP4190324A4 (en) * | 2020-07-31 | 2024-08-14 | Otsuka Pharmaceutical Factory, Inc. | NUTRITION FORMULATION |
| EP4561373A1 (en) * | 2022-07-29 | 2025-06-04 | Abbott Laboratories | Methods for promoting healthy catch-up growth |
| CN117158379B (zh) * | 2023-09-27 | 2026-04-17 | 安徽医科大学 | 一种小鼠孕期宫内生长受限模型及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL126474A (en) | 1996-04-12 | 2001-03-19 | Beth Israel Hospital | Diabetic supplement bar |
| AUPO272196A0 (en) * | 1996-10-02 | 1996-10-24 | Horton, David Robert | Filtration apparatus |
| EP0880902A1 (fr) | 1997-05-27 | 1998-12-02 | Nestlé Produkte AG | Procédé de traitement d'une matiére première lactosérique |
| AU771754B2 (en) | 1999-06-29 | 2004-04-01 | New Zealand Milk Institute Limited, The | Prophylactic dietary supplement based on milk |
| CA2444470A1 (en) | 2001-04-10 | 2002-10-24 | Societe Des Produits Nestle S.A. | Method and composition for prophylaxis of diabetes |
| JP4440918B2 (ja) | 2003-02-10 | 2010-03-24 | ユニバーシティ カレッジ ロンドン | 乳児に授乳する人工乳およびシステム |
| AU2003270130A1 (en) | 2003-08-30 | 2005-03-16 | Nestec S.A. | Acid soluble proteins from micellar casein |
| EA200601575A1 (ru) | 2004-03-01 | 2007-06-29 | Пептера Фармасьютикалс Лтд. | Казеиновые пептиды и их терапевтическое применение |
| AU2006266546B2 (en) | 2005-07-01 | 2012-01-12 | N.V. Nutricia | Infant nutrition with hydrolised proteins |
| PT1940248E (pt) | 2005-10-05 | 2010-01-26 | Nestec Sa | Utilização de uma composição nutricional para promoção do crescimento acelerado |
| WO2008054192A1 (en) | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Use of nutritional compositions for preventing disorders |
| BRPI0706795A2 (pt) * | 2006-01-31 | 2011-04-05 | Nestec Sa | composição nutricional para bebês com baixo peso de nascimento |
| DE102006052560B4 (de) | 2006-11-06 | 2010-01-21 | Humana Milchunion Eg | Anti-diabetogene Calcium-Peptid-Zusammensetzung |
| EP1932437A1 (en) * | 2006-12-15 | 2008-06-18 | Nestec S.A. | Infant formula |
-
2010
- 2010-03-26 BR BRPI1014065A patent/BRPI1014065A2/pt not_active IP Right Cessation
- 2010-03-26 SG SG2011065695A patent/SG174355A1/en unknown
- 2010-03-26 CA CA2755860A patent/CA2755860A1/en not_active Abandoned
- 2010-03-26 US US13/260,817 patent/US8846612B2/en active Active
- 2010-03-26 ES ES10710358T patent/ES2570461T5/es active Active
- 2010-03-26 MY MYPI2011004264A patent/MY183275A/en unknown
- 2010-03-26 MX MX2011010454A patent/MX2011010454A/es active IP Right Grant
- 2010-03-26 EP EP10710358.2A patent/EP2413952B2/en not_active Not-in-force
- 2010-03-26 WO PCT/EP2010/054032 patent/WO2010112430A1/en not_active Ceased
- 2010-03-26 PL PL10710358T patent/PL2413952T3/pl unknown
- 2010-03-26 RU RU2011144581/15A patent/RU2011144581A/ru unknown
- 2010-03-26 CN CN2010800153717A patent/CN102378632A/zh active Pending
- 2010-03-26 AU AU2010230283A patent/AU2010230283B2/en not_active Ceased
- 2010-04-02 TW TW099110445A patent/TW201039754A/zh unknown
-
2011
- 2011-10-03 CL CL2011002465A patent/CL2011002465A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20120021977A1 (en) | 2012-01-26 |
| EP2413952A1 (en) | 2012-02-08 |
| AU2010230283B2 (en) | 2015-02-05 |
| ES2570461T3 (es) | 2016-05-18 |
| CA2755860A1 (en) | 2010-10-07 |
| TW201039754A (en) | 2010-11-16 |
| US8846612B2 (en) | 2014-09-30 |
| EP2413952B1 (en) | 2016-03-23 |
| EP2413952B2 (en) | 2019-10-02 |
| SG174355A1 (en) | 2011-10-28 |
| ES2570461T5 (es) | 2020-04-03 |
| BRPI1014065A2 (pt) | 2016-04-12 |
| AU2010230283A1 (en) | 2011-10-13 |
| RU2011144581A (ru) | 2013-05-10 |
| MX2011010454A (es) | 2012-01-25 |
| WO2010112430A1 (en) | 2010-10-07 |
| MY183275A (en) | 2021-02-18 |
| CN102378632A (zh) | 2012-03-14 |
| PL2413952T3 (pl) | 2017-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2011002465A1 (es) | Uso de una fuente de proteina bovina que comprende caseina para mejorar el crecimiento a una edad temprana y/o reducir el riesgo de desarrollo de resistencia a la insulina o diabetes tipo 2 mas adelante en la vida del bebe o nino pequeno | |
| CY1121042T1 (el) | Φαρμακοτεχνικες μορφες ινσουλινων μακρας-δρασεως | |
| CY1123836T1 (el) | Κατασκευασματα αυξητικου παραγοντα διαφοροποιησης 15(gdf-15) | |
| MX2016006577A (es) | Uso de composiciones nutritivas que tienen una cantidad baja de proteina. | |
| CY1124135T1 (el) | Δοσολογικα σχηματα για την αγωγη της νοσου ρομρε | |
| CL2013000594A1 (es) | Composicion que comprende hidrolizado de proteina en base lactea que proviene del tratamiento de una solucion de un material proteinaceo de base lactea con al menos una endopeptidasa tipo tripsina, y una endopeptidasa tipo quimotripsina; uso de dicha composicion como fórmula infantil o complemento alimenticio para inducción de tolerancia oral en infantes o pacientes que lo necesitan, o para reducir el riesgo de alergias. | |
| EA201491413A1 (ru) | Полипептиды фактора роста и дифференцировки 15 (gdf-15) | |
| GT201500081A (es) | Derivados de exendina-4 como agonistas duales de glp1/glucagón | |
| UY35231A (es) | Agonistas duales de GLP1/GIP o trigonales de GLP1/GIP/Glucagón | |
| AR091422A1 (es) | Analogos peptidicos de la exendina 4 | |
| AR098741A1 (es) | Agonistas duales del receptor de glp-1 (péptido similar al glucagón 1) / glucagón | |
| CL2016000950A1 (es) | Composición farmacéutica acuosa que comprende insulina glulisina y metionina; kit farmacéutico; uso en el tratamiento de la diabetes tipo 1 ó 2. | |
| CR20120026A (es) | Construcciones novedosas de proteína del virus de papiloma humano (hpv) y su uso en la prevención de la enfermedad por el hpv | |
| CR10290A (es) | Metodos para reducir la aglomeracion de proteina | |
| CL2007003584A1 (es) | Alimento para animales que utiliza krill como toda o parte de una fuente de proteina del alimento que comprende que se usa krill sin caparazon; y metodo para minimizar la reduccion en la tasa de crecimiento de los peces causada por el uso del krill c | |
| MX2015014007A (es) | Tratamiento de la diabetes mellitus mediante formulaciones de insulinas de accion prolongada. | |
| BR112012015597A2 (pt) | peptídeos de somatotropina suínos modificados e seus usos | |
| CL2015003634A1 (es) | Formulación de relación fija de insulina glargina/lixisenatida | |
| BR112014009225A2 (pt) | uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes | |
| MX363670B (es) | Formulaciones de bromocriptina. | |
| CL2017002293A1 (es) | Tratamiento de pacientes con diabetes mellitus de tipo 2 | |
| CY1117854T1 (el) | Πεπτιδικη φαρμακοτεχνικη μορφη για τοπικη οφθαλμικη χρηση | |
| AR084495A1 (es) | Dispositivo para dormir | |
| ES2452034T5 (es) | Composición para el cuidado de prótesis dental | |
| CL2011001734A1 (es) | Composición nutricional para infantes que comprende una fuente de proteína, una fuente de lípido y una fuente de carbohidrato, donde la fuente de lípido comprende ácido linoléico y ácido alfa-linolénico |